全文获取类型
收费全文 | 19781篇 |
免费 | 1751篇 |
国内免费 | 29篇 |
专业分类
耳鼻咽喉 | 179篇 |
儿科学 | 601篇 |
妇产科学 | 397篇 |
基础医学 | 2689篇 |
口腔科学 | 588篇 |
临床医学 | 2332篇 |
内科学 | 4044篇 |
皮肤病学 | 254篇 |
神经病学 | 1956篇 |
特种医学 | 597篇 |
外国民族医学 | 3篇 |
外科学 | 2123篇 |
综合类 | 419篇 |
一般理论 | 18篇 |
预防医学 | 2197篇 |
眼科学 | 422篇 |
药学 | 1434篇 |
中国医学 | 10篇 |
肿瘤学 | 1298篇 |
出版年
2022年 | 163篇 |
2021年 | 324篇 |
2020年 | 201篇 |
2019年 | 286篇 |
2018年 | 318篇 |
2017年 | 268篇 |
2016年 | 281篇 |
2015年 | 322篇 |
2014年 | 461篇 |
2013年 | 621篇 |
2012年 | 1002篇 |
2011年 | 995篇 |
2010年 | 533篇 |
2009年 | 464篇 |
2008年 | 895篇 |
2007年 | 928篇 |
2006年 | 902篇 |
2005年 | 904篇 |
2004年 | 930篇 |
2003年 | 820篇 |
2002年 | 742篇 |
2001年 | 606篇 |
2000年 | 611篇 |
1999年 | 531篇 |
1998年 | 255篇 |
1997年 | 190篇 |
1996年 | 195篇 |
1995年 | 217篇 |
1994年 | 176篇 |
1993年 | 179篇 |
1992年 | 471篇 |
1991年 | 432篇 |
1990年 | 432篇 |
1989年 | 414篇 |
1988年 | 353篇 |
1987年 | 337篇 |
1986年 | 296篇 |
1985年 | 294篇 |
1984年 | 223篇 |
1983年 | 214篇 |
1982年 | 171篇 |
1981年 | 146篇 |
1980年 | 143篇 |
1979年 | 235篇 |
1978年 | 160篇 |
1977年 | 147篇 |
1976年 | 157篇 |
1974年 | 150篇 |
1973年 | 169篇 |
1972年 | 141篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
2.
Nurse perceptions of the Nursing Delirium Screening Scale in two palliative care inpatient units: a focus group study
下载免费PDF全文
![点击此处可从《Journal of clinical nursing》网站下载免费的PDF全文](/ch/ext_images/free.gif)
3.
Rian M. Hasson Kayla A. Fay Joseph D. Phillips Timothy M. Millington David J. Finley 《American journal of surgery》2021,221(4):725-730
BackgroundRural populations face many health disadvantages compared to urban areas. There is a critical need to better understand the current lung cancer screening landscape in these communities to identify targeted areas to improve the impact of this proven tool.MethodsData from the County Health Rankings of New Hampshire and Vermont was reviewed for population density, distribution of adult smokers, and level of education compared to the distribution of Lung Cancer Screening Facilities throughout these two states.ResultsScreening programs in southern counties of Vermont with lower levels of education have decreased access. In New Hampshire, there are no programs within 30 miles of the areas with the largest distribution of smokers, and decreased access in some areas with the lowest levels of education.ConclusionsImproving equitable access to high-quality screening services in rural regions and the creation of targeted interventions to address decreased access in areas of high tobacco use and low education is vital to decreasing the incidence of latestage presentations of lung cancer within these populations. 相似文献
4.
Catherine L. Omosule Dominique Joseph Brooke Weiler Victoria L. Gremminger Spencer Silvey Youngjae Jeong Ashique Rafique Pamela Krueger Sandra Kleiner Charlotte L. Phillips 《Journal of bone and mineral research》2022,37(5):938-953
Osteogenesis imperfecta (OI) is a collagen-related bone disorder characterized by fragile osteopenic bone and muscle weakness. We have previously shown that the soluble activin receptor type IIB decoy (sActRIIB) molecule increases muscle mass and improves bone strength in the mild to moderate G610C mouse model of OI. The sActRIIB molecule binds multiple transforming growth factor-β (TGF-β) ligands, including myostatin and activin A. Here, we investigate the musculoskeletal effects of inhibiting activin A alone, myostatin alone, or both myostatin and activin A in wild-type (Wt) and heterozygous G610C (+/G610C) mice using specific monoclonal antibodies. Male and female Wt and +/G610C mice were treated twice weekly with intraperitoneal injections of monoclonal control antibody (Ctrl-Ab, Regn1945), anti-activin A antibody (ActA-Ab, Regn2476), anti-myostatin antibody (Mstn-Ab, Regn647), or both ActA-Ab and Mstn-Ab (Combo, Regn2476, and Regn647) from 5 to 16 weeks of age. Prior to euthanasia, whole body composition, metabolism and muscle force generation assessments were performed. Post euthanasia, hindlimb muscles were evaluated for mass, and femurs were evaluated for changes in microarchitecture and biomechanical strength using micro–computed tomography (μCT) and three-point bend analyses. ActA-Ab treatment minimally impacted the +/G610C musculoskeleton, and was detrimental to bone strength in male +/G610C mice. Mstn-Ab treatment, as previously reported, resulted in substantial increases in hindlimb muscle weights and overall body weights in Wt and male +/G610C mice, but had minimal skeletal impact in +/G610C mice. Conversely, the Combo treatment outperformed ActA-Ab alone or Mstn-Ab alone, consistently increasing hindlimb muscle and body weights regardless of sex or genotype and improving bone microarchitecture and strength in both male and female +/G610C and Wt mice. Combinatorial inhibition of activin A and myostatin more potently increased muscle mass and bone microarchitecture and strength than either antibody alone, recapturing most of the observed benefits of sActRIIB treatment in +/G610C mice. © 2022 American Society for Bone and Mineral Research (ASBMR). 相似文献
5.
6.
Marjorie Shaw Phillips Roger L Williams 《American journal of health-system pharmacy》2006,63(2):139-142
PURPOSE: Recommendations of the interdisciplinary Safe Medication Use Expert Committee of the United States Pharmacopeia (USP) to assist health care professionals, manufacturers, and organizations in handling neuromuscular blocking agents (NMBAs) safely and effectively are discussed. SUMMARY: Review and analysis of the USP Medication Errors Reporting Program and MEDMARX program databases showed a continuing risk of patient harm or death due to errors with NMBAs. Medication errors involving wrong concentrations, wrong doses, wrong drugs, look-alike packaging, and sound-alike names, combined with lack of monitoring and communication, have been associated with the use of NMBAs in health care institutions. Serious adverse events occur when NMBAs are used without adequate safeguards. Recommendations for improving safety were developed through review and discussion of root causes and areas of concern with these medications. CONCLUSION: Medical errors with NMBAs continue to result in patient morbidity and mortality. Increased awareness and action on the part of all parties involved are needed to improve the safety of this class of medications. 相似文献
7.
8.
K A Phillips 《The Journal of clinical psychiatry》1991,52(12):514-515
9.
10.
G E Davies A V Thompson Z Niewola G E Burrows E L Teasdale D J Bird D A Phillips 《Occupational and environmental medicine》1983,40(4):442-449
Twenty four volunteers who had been allergic to laboratory animals for some years were examined by means of a questionnaire paying particular attention to symptoms associated with rats and by serological and skin tests with extracts of rat urine (retrospective study). Nasal and eye symptoms were reported by 21 and 16 individuals respectively: 13 had asthma. Positive skin tests and high levels of specific IgE antibody to rat urine extract were found in 17 of the more severely affected individuals and this group included 12 of those with asthma. Latent periods of work with animals before symptoms appeared varied from 0.5 to 12 years. Also 148 individuals were studied during their first year of work with animals (prospective study). Symptoms developing during the year were reported by 15%, asthma by 2%. IgE antibody levels to rat urine were raised in 40% of affected and 6% of the unaffected individuals but there was no significant correlation between symptoms and either antibody levels or positive skin tests. Allergic symptoms developing during the first year of postemployment were, on the whole, much milder than those seen in the retrospective study. A tentative conclusion is that most individuals who become allergic to laboratory animals develop the condition in a mild form during their first year of employment but it appears probable that atopic individuals, although having an equal chance of developing allergy as compared with non-atopic individuals, may eventually progress to a more severe form of the disease. 相似文献